ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,590.74
      -0.77%
      US Tech 100
      19,738.00
      -1.89%
      Dow Jones
      39,771.03
      0.13%
      Brent Oil
      84.855
      -0.23%
      Bitcoin
      57,641.46
      -0.20%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Harpoon Therapeutics Inc (HARP)

      7. Harpoon Therapeutics Inc (HARP) News

      HARP

      Harpoon Therapeutics (HARP)

      Harpoon Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:HARP
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      09/01/202312:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HARPHarpoon Therapeutics Inc
      08/09/20234:31PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HARPHarpoon Therapeutics Inc
      08/09/20234:25PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HARPHarpoon Therapeutics Inc
      08/09/20234:01PMGlobeNewswire Inc.Harpoon Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:HARPHarpoon Therapeutics Inc
      08/03/20237:30AMGlobeNewswire Inc.Harpoon Therapeutics to Participate in Two Upcoming Investor Conferences in AugustNASDAQ:HARPHarpoon Therapeutics Inc
      08/01/20237:30AMGlobeNewswire Inc.Harpoon Therapeutics Appoints Haibo Wang as Senior Vice President of Business DevelopmentNASDAQ:HARPHarpoon Therapeutics Inc
      07/10/20239:00AMPR Newswire (US)Replicate Bioscience Appoints Rachael Lester as Chief Business OfficerNASDAQ:HARPHarpoon Therapeutics Inc
      07/06/20236:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HARPHarpoon Therapeutics Inc
      06/27/20237:30AMGlobeNewswire Inc.Harpoon Therapeutics Announces Completion of Planned Patient Enrollment in Phase 1 Study of HPN217 in Relapsed/Refractory Multiple MyelomaNASDAQ:HARPHarpoon Therapeutics Inc
      06/23/20234:55PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HARPHarpoon Therapeutics Inc
      06/23/20234:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HARPHarpoon Therapeutics Inc
      06/23/20234:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HARPHarpoon Therapeutics Inc
      06/23/20234:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HARPHarpoon Therapeutics Inc
      06/23/20234:29PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HARPHarpoon Therapeutics Inc
      05/31/20236:03AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:HARPHarpoon Therapeutics Inc
      05/16/20236:09AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:HARPHarpoon Therapeutics Inc
      05/16/20236:06AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:HARPHarpoon Therapeutics Inc
      05/12/20236:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HARPHarpoon Therapeutics Inc
      05/11/20234:37PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:HARPHarpoon Therapeutics Inc
      05/11/20234:30PMGlobeNewswire Inc.Harpoon Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:HARPHarpoon Therapeutics Inc
      05/11/20234:10PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:HARPHarpoon Therapeutics Inc
      04/27/20234:34PMEdgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:HARPHarpoon Therapeutics Inc
      04/21/20235:18PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:HARPHarpoon Therapeutics Inc
      04/18/20231:30PMGlobeNewswire Inc.Harpoon Therapeutics Presents Preclinical Results for Novel T Cell Engagers HPN217 and HPN328 at AACR 2023NASDAQ:HARPHarpoon Therapeutics Inc
      04/17/20231:30PMGlobeNewswire Inc.Harpoon Therapeutics Presents Data for New ProTriTAC™ Development Candidates in TROP2- and ITGB6-expressing Solid Tumors at AACR 2023NASDAQ:HARPHarpoon Therapeutics Inc
      04/10/20234:05PMGlobeNewswire Inc.Harpoon Therapeutics to Participate in the Canaccord Horizons in Oncology ConferenceNASDAQ:HARPHarpoon Therapeutics Inc
      04/07/20234:16PMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:HARPHarpoon Therapeutics Inc
      04/04/20235:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HARPHarpoon Therapeutics Inc
      04/04/20235:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HARPHarpoon Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:HARP